By Michele Maatouk
Date: Wednesday 24 Dec 2025
(Sharecast News) - France's Sanofi said on Wednesday that it has agreed to buy US hepatitis vaccine maker Dynavax in a $2.2bn deal.
By Benjamin Chiou
Date: Monday 15 Dec 2025
(Sharecast News) - Sanofi's stock was in the red on Monday after the pharma group gave two disappointing updates regarding its tolebrutinib treatment for multiple sclerosis.
By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
| Currency | Euro |
| Share Price | 81.19 |
| Change Today | -1.13 |
| % Change | -1.37 % |
| 52 Week High | 109.62 |
| 52 Week Low | 77.52 |
| Volume | 1,296,572 |
| Shares Issued | 1,256.00m |
| Market Cap | 101,975m |
| Beta | 0.82 |
| Strong Buy | 13 |
| Buy | 7 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 27 |

| Time | Volume / Share Price |
| 17:38 | 100 @ 81.19 |
| 17:38 | 100 @ 81.19 |
| 17:38 | 100 @ 81.19 |
| 17:38 | 580 @ 81.19 |
| 17:38 | 150 @ 81.19 |
You are here: research